Archives: Events

AskBio's Sheila Ann Mikhail joined Matter's Tales from the Trenches to share her entrepreneurial journey, her perseverance and vision for AskBio and lessons learned throughout her career.

AskBio's Graham Whyteside, PhD, Director, Platform R&D, AskBio Europe, spoke at the Synthetic Biology-Based Therapeutic Summit on Advancing Synthetic Promoter Design.

What does it take to shatter the glass ceiling in biopharma R&D? Calls to diversify the biopharma industry have grown louder over the last year, and in response, more companies have made laudable efforts to address the issue. AskBio's Sheila Mikhail sat down with other leaders from across the biopharma industry to discuss breaking the […]

More than 200 NCBIO members and invited guests come together to enjoy a program of speakers and panels addressing current topics of importance to the industry. Keynote speaker Jude Samulksi, Ph.D., President and CSO of AskBio will share about his start in North Carolina, current issues and what comes next in the biotechnology space.

Advanced Therapies Week is the destination for anyone developers, investors or those interested in cell and gene therapies and tissue engineered products. Throughout the week, the organizers be host a variety of networking events, focused roundtables and content sessions designed to help biotechs advance along their commercialization journey.Speaker: Sheila Mikhail, CEO & Co-Founder, AskBioPresentation & Q&A Panel

Pre-Recorded Company Presentation by Sheila Mikhail, CEO & Co-Founder, AskBio

Company Presentation (Fireside Chat Format)

Dual Dialogue – Anatomy of an Acquisition: Bayer and AskBio

The World Orphan Drug Congress has become the industry defining meeting on Advanced Therapies for rare diseases, featuring discussions on clinical development, manufacturing and commercialization of cell and gene therapies, as well the annual gathering for artificial intelligence and digital health solutions transforming the rare disease industry.

The 2021 STAT Breakthrough Science Summit will take you inside these innovations, examining how they're being developed, adopted, and paid for. We'll also take a look at the breakthroughs that haven't yet hit the market, but have the potential to redefine health and medicine in the years to come.